{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-237665","form_type":"8-K","ticker":"WVE","cik":"0001631574","company_name":"Wave Life Sciences Ltd.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.041952+00:00","generated_at":"2026-05-30T14:36:21.506361+00:00","sec_items":["7.01","8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Takeda terminates HTT option; Wave Life Sciences regains full rights to WVE-003 Huntington's program","bullets":["Takeda notified Wave it will not exercise option for HTT target, ending collaboration; Takeda previously paid ~$260M to Wave.","Wave regains full rights to WVE-003 and all HTT-targeting programs, with potential $5B-$10B commercial opportunity.","SELECT-HD clinical trial data generated significant interest from prospective partners for WVE-003.","Wave expects regulatory feedback on accelerated approval pathway for WVE-003 by end of 2024.","Cash runway unchanged into 2027, excluding potential GSK milestones."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-237665","json":"https://secwatch.observer/filing/0001193125-24-237665.json","markdown":"https://secwatch.observer/filing/0001193125-24-237665.md","text":"https://secwatch.observer/filing/0001193125-24-237665.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1631574/000119312524237665/0001193125-24-237665-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1631574/000119312524237665/d899308d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:36:21.506361+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}